Placebos

Patients taking placebo and statins experience similar side effects

Patients experience similar side effects taking a placebo as they do taking a statin, a study in the New England Journal of Medicine has suggested.…

Trial confirms antiepileptic effects of fenfluramine in children with Dravet syndrome

Children with Dravet syndrome, a severe form of epilepsy that is resistant to treatment, experience fewer seizures when treated with fenfluramine, a phase III trial published in The Lancet has confirmed.…

Novel migraine therapy relieves pain and bothersome symptoms

Rimegepant, a medicine belonging to a new class of migraine treatments, relieves pain and other symptoms in patients with moderate or severe migraine pain, research published in The New England Journal of Medicine has shown.…

Alzheimer’s drug reduces illicit opioid use in methadone recipients

People who take methadone use fewer illicit opioids when galantamine is added to their therapy, research shows.…

Esketamine nasal spray effective for rapid improvement of depressive symptoms

The ketamine-related nasal spray esketamine is effective at relieving the symptoms of treatment-resistant depression, a phase III study has shown.…

Dulaglutide injection reduces risk of cardiovascular outcomes in type 2 diabetes mellitus by 12%

A weekly dulaglutide injection in addition to existing medication reduces the risk of cardiovascular outcomes in individuals with type 2 diabetes mellitus, compared with placebo, a study published in The Lancet has found.…

No benefit to daily aspirin in healthy older people

Daily low-dose aspirin does not increase the duration of disability-free life in healthy older people, trial results published in the New England Journal of Medicine have shown.…

Dupilumab helps severe asthma patients cut glucocorticoid use

Research has shown dupilumab reduces glucocorticoid use by more than 70% and the number of severe asthma exacerbations by almost 60%.…

Cannabidiol reduces seizure rate in rare form of epilepsy

Cannabidiol reduces the risk of drop seizures in people with Lennox-Gastaut syndrome, a rare, severe form of epilepsy, according to the results of a recent study…

DPP-4 inhibitors have no mortality benefit in type 2 diabetes, analysis shows

Dipeptidyl peptidase-4 (DPP-4) inhibitors do not lower death rates in patients with type 2 diabetes, an analysis comparing them with other common treatments has shown.…